Chimeric Antigen Receptor (CAR) therapy for multiple myeloma

British Journal of Haematology
Djordje AtanackovicTim Luetkens

Abstract

The introduction of chimeric antigen receptor (CAR)-modified T cells has revolutionized immunotherapy and cancer treatment as a whole. However, so far, clinical efficacy has only been demonstrated for CD19-positive B cell lymphomas. For Multiple Myeloma (MM), the second most common haematological malignancy, there are currently no clinical results supporting the usefulness of the adoptive transfer of CAR-modified T cells. This might be related to the fact that an ideal surface target has not yet been identified or the presence of strong local immunosuppression in the tumour microenvironment, which is a hallmark of MM. In this review, we provide a comprehensive overview of promising target molecules for CAR T cell approaches in MM and we outline a number of ways in which the local immunosuppression in MM can be overcome. By providing a strategy for the design of CAR T cell treatments for MM we hope to transform this new therapeutic approach into a valuable tool within the therapeutic armamentarium for MM.

References

Nov 1, 1991·British Journal of Haematology·I Van RietB Van Camp
Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·L ClaessonP A Peterson
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·E L ReinherzS F Schlossman
Aug 1, 1996·British Journal of Haematology·J WijdenesJ M Dore
Jun 20, 2002·Trends in Immunology·A Neil BarclayMarion H Brown
Jul 2, 2002·Blood·Yang YangRalph D Sanderson
Nov 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tomohide YamazakiHideo Yagita
Sep 3, 2003·Nature Reviews. Cancer·Mark E Dudley, Steven A Rosenberg
Oct 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jack D BurtonDavid M Goldenberg
Apr 14, 2006·British Journal of Haematology·B D HockJ L McKenzie
May 9, 2006·Critical Care : the Official Journal of the Critical Care Forum·Douglas F Larson, Katherine Horak
Jul 28, 2006·The Journal of Biological Chemistry·Achilleas D TheocharisAnders Hjerpe
Sep 2, 2006·Blood·Jerome MoreauxBernard Klein
Mar 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert H VonderheideScott J Antonia
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rhona SteinDavid M Goldenberg
Oct 26, 2007·The New England Journal of Medicine·Marshall R PosnerUNKNOWN TAX 324 Study Group
Jan 8, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anke Kretz-RommelKatherine S Bowdish
May 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric D HsiMarna B Williams
Sep 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Taishi YamashitaKiyoyuki Ogata
Mar 4, 2009·Current Problems in Cancer·S Vincent Rajkumar
May 21, 2009·Seminars in Musculoskeletal Radiology·Andrea Baur-Melnyk, Maximilian F Reiser

❮ Previous
Next ❯

Citations

Oct 25, 2016·International Journal of Molecular Sciences·Philip EganH Denis Alexander
Nov 1, 2016·Expert Review of Hematology·Antonino NeriPellegrino Musto
Apr 27, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pellegrino Musto
Apr 22, 2017·Cancer Treatment Reviews·Leo RascheFaith E Davies
Dec 7, 2016·Blood·Jacalyn Rosenblatt, David Avigan
Jan 26, 2017·Clinical and Experimental Medicine·Hailing LiuFuling Zhou
Jan 10, 2018·Nature Reviews. Clinical Oncology·Irene M GhobrialDavid P Steensma
Feb 7, 2018·Frontiers in Immunology·Aurélie DurgeauFathia Mami-Chouaib
Sep 21, 2017·Blood·Lekha Mikkilineni, James N Kochenderfer
Jun 10, 2017·Current Stem Cell Reports·Juliette M K M Delhove, Waseem Qasim
Mar 7, 2020·Cells·Cinnie Yentia SoekojoWee Joo Chng
Aug 27, 2016·Oncotarget·Aneta SchieferdeckerFrancis Ayuk
Aug 31, 2017·Journal of Hematology & Oncology·Mingxue FanLei Yu
May 8, 2018·Journal of Leukocyte Biology·Pan LiuFuling Zhou
May 17, 2019·Journal of Oncology·Rachel E CookeDavid Ritchie
Feb 23, 2019·Frontiers in Immunology·Javier Redondo-MuñozJoaquin Teixidó
Aug 6, 2019·Frontiers in Immunology·Marijke TimmersSébastien Anguille
Jun 24, 2020·Leukemia·Nico GagelmannNicolaus Kröger
Aug 28, 2020·Cell Communication and Signaling : CCS·Dongfang LiuChen Liu
Jan 30, 2021·Life Sciences·Nastaran HashemzadehJaleh Barar
Jan 12, 2021·Bulletin du cancer·David BeauvaisIbrahim Yakoub-Agha
Jul 23, 2020·Molecular Therapy. Methods & Clinical Development·Yan YangDongfang Liu
Aug 28, 2021·International Journal of Molecular Sciences·Theresa HaslauerRoland Geisberger

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Robert O CarpenterJames N Kochenderfer
Current Opinion in Immunology
Michael C Jensen, Stanley R Riddell
Hematology/oncology Clinics of North America
Marco L Davila, Renier J Brentjens
© 2022 Meta ULC. All rights reserved